Amarin Corp Plc (AMRN)

[sstyles]

While it would be great to get an en banc hearing, we don't really need it so long as the GSK v. Teva case remains in litigation.

Newman came through for us in a major way. That case could be stuck in the courts for a few more years with en banc plus possible appeal to Supreme Court. Generics are not making a huge investment nor trying to procure supply with GSK v. Teva hanging in the balance. They too have fallen victim to the courts. It happens.

Of course if Teva does not get an en banc hearing, then it's really game over for generics. Either way they are sidelined right now because of the damages and what they could add up to.

Perhaps Amarin and generics will now settle.....only time will tell.